About orasure technologies inc. - OSUR
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offers oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in 2000 in and is headquartered in Bethlehem, PA.
OSUR At a Glance
OraSure Technologies, Inc.
220 East 1st Street
Bethlehem, Pennsylvania 18015
| Phone | 1-610-882-1820 | Revenue | 115.02M | |
| Industry | Medical Specialties | Net Income | -68,731,000.00 | |
| Sector | Health Technology | Employees | 501 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
OSUR Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.546 |
| Price to Book Ratio | 0.50 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.336 |
| Enterprise Value to Sales | 0.169 |
| Total Debt to Enterprise Value | 2.102 |
OSUR Efficiency
| Revenue/Employee | 229,582.834 |
| Income Per Employee | -137,187.625 |
| Receivables Turnover | 5.18 |
| Total Asset Turnover | 0.261 |
OSUR Liquidity
| Current Ratio | 6.581 |
| Quick Ratio | 5.801 |
| Cash Ratio | 5.008 |
OSUR Profitability
| Gross Margin | 36.978 |
| Operating Margin | -59.227 |
| Pretax Margin | -56.151 |
| Net Margin | -59.755 |
| Return on Assets | -15.571 |
| Return on Equity | -18.30 |
| Return on Total Capital | -18.005 |
| Return on Invested Capital | -17.536 |
OSUR Capital Structure
| Total Debt to Total Equity | 12.003 |
| Total Debt to Total Capital | 10.717 |
| Total Debt to Total Assets | 10.147 |
| Long-Term Debt to Equity | 5.957 |
| Long-Term Debt to Total Capital | 5.319 |